Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

This clinical trial investigates the effect of non-chemotherapeutic interventions in patients with multiple myeloma or MDS. Non-chemotherapeutic interventions such as physical activity and nutritional interventions (e.g., modifications in diet) have been shown to positively affect the immune system and improve overall quality of life. Another purpose of this study is for researchers to learn how the addition of a beta-blocker (propranolol) to the standard treatment regimen in patients with newly diagnosed multiple myeloma affects immune response and quality of life. A study from the Mayo Clini

Trial Details

NCT ID

NCT05312255

Phase

Sponsor

Roswell Park Cancer Institute

Status

RECRUITING

Cancer Type

Newly Diagnosed Multiple Myeloma

Interventions

Behavioral Intervention
Beta-Adrenergic Antagonist
Propranolol
Quality-of-Life Assessment
Questionnaire Administration
Resistance Training

Locations (sample)

Buffalo, New York, United States|42.88645,-78.87837

Key Eligibility Criteria

Age \>= 18 years of age
Have an Eastern Cooperative Oncology Group (ECOG) Performance Status of:
Module A: ECOG 0 - 1
Module B: ECOG 0 - 2

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Newly Diagnosed Multiple Myeloma Trials on Trialify →